Bharat Biotech To Produce Additional 200 M Covaxin In Gujarat
India will now receive vaccines in the market as Health Minister Mansukh Mandaviya has released the first commercial batch of COVID-19 vaccine "Covaxin" developed by Bharat Biotech in its new plant, based in Gujarat's Ankleshwar on August 29. Reportedly, the Hyderabad-based firm in may announced to open the plant to produce 200 million doses of vaccine. Mandaviya also said that it will strengthen the country's fight against coronavirus.